Direct comparative studies are needed of the safety and efficacy of drugs used to treat neuropathic pain.

BHV-2100 is under clinical development by Biohaven and currently in Phase II for Neuropathic Pain (Neuralgia).

This type of pain can be severe and more difficult to treat. Nerve pain is typically treated with prescription-strength medications, but some over-the-counter products, primarily topical creams ...

AFA-281 is under clinical development by AfaSci and currently in Phase I for Neuropathic Pain (Neuralgia). According to GlobalData, Phase I drugs for Neuropathic Pain (Neuralgia) have a 76% phase ...

Currently, gabapentinoids are within the ten most subsidised medications by volume in ... said gabapentinoids can be effective for neuropathic pain but can also result in adverse events including ...

The efficacy of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy has been established in several controlled clinical trials. [17,18,19] These trials ...

Medically reviewed by William Truswell, MD Hidradenitis suppurativa (HS) is a chronic (long-term) inflammatory skin condition ...

Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...

Cellular research indicates that neuropilin-1 plays a crucial role in pain signaling, presenting a potential pathway for ...

A new study has found a potential breakthrough in the treatment of chronic pain and doesn't rely on addictive opiate ...

The medication is meant to be a non-addictive alternative to opioids, and has shown in multiple clinical trials the ability ...

Also Read: MIRA Pharmaceuticals’ Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain The company says that by demonstrating Ketamir-2’s robust safety ...